| Biological Sciences | Lifetime | 793 | DE 46 | 99.90 |
| Medical and Health Sciences | 2021-2025 | 628 | DE 43 | 99.86 |
| Biological Sciences | 2021-2025 | 346 | DE 17 | 99.64 |
| Oncology | Lifetime | 20 | DE 2 | 99.96 |
| Molecular Biology | Lifetime | 274 | DE 17 | 99.87 |
| Immunology | Lifetime | 175 | DE 8 | 99.61 |
| Dermatology | Lifetime | 518 | DE 55 | 95.94 |
| Oncology | 2021-2025 | 15 | DE 2 | 99.91 |
| Molecular Biology | 2021-2025 | 102 | DE 4 | 99.59 |
| Immunology | 2021-2025 | 180 | DE 13 | 96.01 |
| Epidemiology | 2021-2025 | 632 | DE 22 | 94.19 |
| Cutaneous Melanoma Detection and Management | Lifetime | 2 | DE 1 | 99.95 |
| CAR-T cell therapy research | Lifetime | 7 | DE 1 | 99.97 |
| Melanoma and MAPK Pathways | Lifetime | 2 | DE 1 | 99.95 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 13 | DE 1 | 99.96 |
| Immunotherapy and Immune Responses | Lifetime | 20 | DE 1 | 99.95 |
| vaccines and immunoinformatics approaches | Lifetime | 20 | DE 3 | 99.58 |
| Nonmelanoma Skin Cancer Studies | Lifetime | 33 | DE 4 | 99.40 |
| HER2/EGFR in Cancer Research | Lifetime | 271 | DE 18 | 98.82 |
| Colorectal Cancer Treatments and Studies | Lifetime | 380 | DE 15 | 98.84 |
| Computational Drug Discovery Methods | Lifetime | 433 | DE 25 | 98.01 |
| Cancer and Skin Lesions | Lifetime | 176 | DE 17 | 98.33 |
| Cell Adhesion Molecules Research | Lifetime | 545 | DE 44 | 98.33 |
| Brain Metastases and Treatment | Lifetime | 245 | DE 17 | 98.15 |
| Polyomavirus and related diseases | Lifetime | 295 | DE 24 | 97.41 |
| Hedgehog Signaling Pathway Studies | Lifetime | 327 | DE 24 | 95.54 |
| melanin and skin pigmentation | Lifetime | 424 | DE 24 | 95.88 |
| Chemokine receptors and signaling | Lifetime | 401 | DE 38 | 94.67 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 484 | DE 55 | 95.66 |
| Cell Image Analysis Techniques | Lifetime | 536 | DE 53 | 93.89 |
| Protein Degradation and Inhibitors | Lifetime | 985 | DE 78 | 93.91 |
| Ocular Oncology and Treatments | Lifetime | 609 | DE 49 | 92.43 |
| Synthesis of Tetrazole Derivatives | Lifetime | 174 | DE 24 | 91.24 |
| CAR-T cell therapy research | 2021-2025 | 9 | DE 1 | 99.86 |
| Immunotherapy and Immune Responses | 2021-2025 | 7 | DE 1 | 99.73 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 23 | DE 1 | 99.89 |
| Cutaneous Melanoma Detection and Management | 2021-2025 | 4 | DE 1 | 99.85 |
| Melanoma and MAPK Pathways | 2021-2025 | 3 | DE 1 | 99.89 |
| Nonmelanoma Skin Cancer Studies | 2021-2025 | 16 | DE 5 | 98.80 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 106 | DE 3 | 98.56 |
| Hedgehog Signaling Pathway Studies | 2021-2025 | 20 | DE 2 | 92.79 |
| Cancer and Skin Lesions | 2021-2025 | 41 | DE 4 | 95.37 |
| Polyomavirus and related diseases | 2021-2025 | 68 | DE 10 | 95.47 |
| Brain Metastases and Treatment | 2021-2025 | 819 | DE 100 | 83.69 |
| Cell Image Analysis Techniques | 2021-2025 | 750 | DE 68 | 76.16 |
| Cancer, Stress, Anesthesia, and Immune Response | 2021-2025 | 534 | DE 7 | 67.32 |
| Ocular Oncology and Treatments | 2021-2025 | 702 | DE 68 | 68.96 |
| TGF-β signaling in diseases | 2021-2025 | 474 | DE 22 | 38.48 |
| Histiocytic Disorders and Treatments | 2021-2025 | 902 | DE 36 | 26.37 |
